Pulse Biosciences Says NANOPULSE-AF Atrial Fibrillation Study Surpasses Enrollment Midpoint After April 2026 Start; Update Due On August 6 Earnings Call

Loading news article.

Pulse Biosciences Says NANOPULSE-AF Atrial Fibrillation Study Surpasses Enrollment Midpoint After April 2026 Start; Update Due On August 6 Earnings Call | WAPE

Pulse Biosciences Says NANOPULSE-AF Atrial Fibrillation Study Surpasses Enrollment Midpoint After April 2026 Start; Update Due On August 6 Earnings Call

Article summary

Related companies

Comments —